An innovative open exchange platform that introduces a new and unique way to price and trade innovative medicines, treatments and devices to government-approved healthcare agencies and institutions. MTX employs a virtual currency issued by manufacturers that is linked to a fixed USD value for each medicine, therapy, or device.

From an asset valuation and financial transparency standpoint, MTX requires manufacturers to issue virtual currencies only after real stocks of regulatory-approved medicines and therapies are available to be produced, sold and distributed in a market/geography.